Delivery Order SPE2DB24D8002-SPE2DB25FJNMN
Award Date
4/9/25
Potential Completion Date
4/10/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a firm fixed price of $1,928.41 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA...
This is a federal contract award by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The contract has an award value of $1,193.01 and a completion date of February 7, 2024. This award is not associated with a set-aside program and is a firm fixed-price delivery order contract. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical...
This contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, valued at $1,179.40, is a Firm Fixed Price Delivery Order against the company's existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a variety of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The contract, identified as SPE2DX15D8002|SPE2DX24F2UW2, has a ceiling value of $4,825.71 and is a Firm Fixed Price Delivery Order with a completion date of February 9, 2024. Dakota Drug, Inc. is a key supplier...
This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of pharmaceutical products, medical supplies, and healthcare equipment. The award, valued at $3,964.31, is a delivery order under a larger Indefinite Delivery Contract (IDC) called SPE2DB24D8001, which has a ceiling value of $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program and allows Dakota...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,881.94 to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, which does not have a set-aside designation, is for the delivery of the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is an Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract falls under the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment. Through this single-award IDC, Dakota Drug, Inc. will provide a comprehensive range of pharmaceutical...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZDT, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, primarily to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,528.94 and is a Firm Fixed Price Delivery Order. It is not associated with a set-aside program. Dakota...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...